Health experts are concerned Ozempic and other GLP-1 agonist drugs may be inappropriately prescribed to people experiencing disordered eating.

Q4 2024 revenue increased 24.6% over Q3 2024; Full-year 2024 revenue grew 97.8% year-over-yearStrong growth in key commercial metrics, including ...

The new craze of using lower-than-recommended dosages of weight loss drugs to slim down might sound tempting, says Charlotte ...

New research shows that extreme weight loss and weight gain significantly increase the risk of death in obese individuals with cardiovascular disease.

Netflix's Apple Cider Vinegar follows influencer Belle Gibson who faked a cancer diagnosis and claimed diet changes cured her ...

MIAMI, FLA. — Shane Smith, president and chief executive officer of Smithfield Foods shared his perspectives on the market ...

Effective obesity-management medication should be subsidised on the Pharmaceutical Benefits Scheme (PBS) to reduce health inequity, the Royal ...

Effective obesity-management medication should be subsidised on the Pharmaceutical Benefits Scheme (PBS) to reduce health inequity, the Royal ...

As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...

For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...

Patients who continued Ozempic through total joint arthroplasty had higher risk for complications compared with those who stopped GLP-1RAs before surgery.